| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |